Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ "CABERNET"

Completed

Phase 3 Results

Summary of Purpose

The primary objective of this study is to demonstrate the safety of the NexStent for treatment of carotid artery lesions undergoing stenting with adjunctive use of the FilterWire distal embolic protection device. The rates will be compared to an Objective Performance Criterion (OPC) derived from historic data from high-risk patients undergoing surgical intervention with Carotid endarterectomy. Patients included...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 January 2008.

1 Dec 2001 14 Jan 2008 1 Mar 2005 1 Jun 2007 1 Jan 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Single Group Assignment

Contacts

Not available